Problems of most small biotech , no money , And NIH putting taxpayers money to do for Gilead 10 studies with remdesivir in covid , but so far nothing for the small companies with great drugs,,
Why are they doing that, Maybe article below will give some light to this question.
Market Data 
Markets 
AI
